Replies to post #286592 on Amarin Corp Plc (AMRN)

[Biobillionair]

Thanks very helpful. Hikma helped spark opioid epidemic & now are totally fine taking out a future drug candidates for the big 3, Alzheimer’s, NASH and cancer....

Hikma Pharmaceuticals is leading the FTSE 250 this morning, up 7.5% at £20.62, after it lifted its sales forecast as it supplies more opioid painkillers to the US which is experiencing a shortage.

Its full-year outlook has been boosted by both its injectables division and its generic drugs business.

BB